Discovery of novel Hsp90 C-terminal inhibitors using 3D-pharmacophores derived from molecular dynamics simulations
Povzetek
Hsp90 C-terminal domain (CTD) inhibitors are promising novel agents for cancer treatment, as they do not induce the heat shock response associated with Hsp90 N-terminal inhibitors. One challenge associated with CTD inhibitors is the lack of a co-crystallized complex, requiring the use of predicted allosteric apo pocket, limiting structure-based (SB) design approaches. To address this, a unique approach that enables the derivation and analysis of interactions between ligands and proteins from molecular dynamics (MD) trajectories was used to derive pharmacophore models for virtual screening (VS) and identify suitable binding sites for SB design. Furthermore, ligand-based (LB) pharmacophores were developed using a set of CTD inhibitors to compare VS performance with the MD derived models. Virtual hits identified by VS with both SB and LB models were tested for antiproliferative activity. Compounds 9 and 11 displayed antiproliferative activities in MCF-7 and Hep G2 cancer cell lines. Compound 11 inhibited Hsp90-dependent refolding of denatured luciferase and induced the degradation of Hsp90 clients without the concomitant induction of Hsp70 levels. Furthermore, compound 11 offers a unique scaffold that is promising for the further synthetic optimization and development of molecules needed for the evaluation of the Hsp90 CTD as a target for the development of anticancer drugs.
Ključne besede
zaviralci;molekularna dinamika;zdravljenje raka;virtualno rešetanje;farmakofori;allosteric;cancer;Hsp90;inhibitor;molecular dynamics;pharmacophores;virtual screening;
Podatki
| Jezik: | Angleški jezik |
|---|---|
| Leto izida: | 2020 |
| Tipologija: | 1.01 - Izvirni znanstveni članek |
| Organizacija: | UL FFA - Fakulteta za farmacijo |
| UDK: | 615.2:616-006-085 |
| COBISS: |
29153795
|
| ISSN: | 1422-0067 |
| Št. ogledov: | 187 |
| Št. prenosov: | 115 |
| Ocena: | 0 (0 glasov) |
| Metapodatki: |
|
Ostali podatki
| Sekundarni jezik: | Slovenski jezik |
|---|---|
| Sekundarne ključne besede: | Rak (medicina); |
| Vrsta dela (COBISS): | Članek v reviji |
| Strani: | str. 1-22 |
| Letnik: | ǂVol. ǂ21 |
| Zvezek: | ǂno. ǂ18 |
| Čas izdaje: | 2020 |
| DOI: | 10.3390/ijms21186898 |
| ID: | 14305987 |
Priporočena dela:
Discovery of novel Hsp90 C-terminal inhibitors using 3D-pharmacophores derived from molecular dynamics simulations
2020,
ni podatka o podnaslovu
In silico discovery and optimisation of a novel structural class of Hsp90 C-terminal domain inhibitors
2022,
ni podatka o podnaslovu
Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma
2022,
ni podatka o podnaslovu
Načrtovanje, sinteza in biološko vrednotenje novih alosteričnih zaviralcev Hsp90 s protitumornim delovanjem
2023,
ni podatka o podnaslovu
Structure-activity relationships of benzothiazole-based Hsp90 C-terminal-domain inhibitors
2021,
ni podatka o podnaslovu